Recordati Industria Chimica e Farmaceutica SpA banner

Recordati Industria Chimica e Farmaceutica SpA
F:RER1

Watchlist Manager
Recordati Industria Chimica e Farmaceutica SpA Logo
Recordati Industria Chimica e Farmaceutica SpA
F:RER1
Watchlist
Price: 50.25 EUR -0.3% Market Closed
Market Cap: €10.4B

Intrinsic Value

The intrinsic value for Recordati Industria Chimica e Farmaceutica SpA (RER1) under the Base Case is 62.39 EUR. Compared with the current market price of 50.25 EUR, the stock appears Undervalued by 19% .

Based on two methods:

Both DCF and multiples point to undervaluation.

RER1 Intrinsic Value
62.39 EUR
Undervaluation 19%
Intrinsic Value
Price €50.25
Bear Case
Base Case
Bull Case
Monitor RER1
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €49.91
Get notified when the price drops into your buy zone
Intrinsic Value €62.39
Current Price €50.25
Margin of Safety 20% €49.91
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about RER1?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is RER1 valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Recordati Industria Chimica e Farmaceutica SpA.

Explain Valuation
Alternatives to RER1

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one RER1 stock?

The intrinsic value for Recordati Industria Chimica e Farmaceutica SpA (RER1) under the Base Case is 62.39 EUR.

Is RER1 stock undervalued or overvalued?

Compared with the current market price of 50.25 EUR, the stock appears Undervalued by 19% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett